Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin superfamily member 5 (IGSF5) is a cell–cell adhesion molecule that localizes to tight junctions in epithelial and endothelial tissues, working with other proteins such as MAGI1 to regulate barrier permeability in organs like the kidney and intestine[2][3][4][7]. IGSF5 mediates calcium-independent homophilic interactions and plays a crucial role in maintaining epithelial barrier integrity[1][2][3][4][7]. In the testis, it may function as a more general adhesion molecule important for spermatogonia and Sertoli cell interactions[3][4]. Genetic variation in IGSF5 is associated with altered transcriptional activity and potentially with phenotypic variability in some developmental disorders[1]. IGSF5 has been implicated as an immune-related prognostic biomarker in head and neck squamous cell carcinoma and associated with other conditions including pseudo-TORCH syndrome 1 and autism spectrum disorder[1][3][4]. While its detailed mechanism and interacting partners are still being characterized, disruption of IGSF5 function can influence intercellular adhesion and tissue integrity, impacting both developmental and disease processes[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin superfamily member 5 (IGSF5).